News

« Back to News List

March 23, 2017

Motley Rice attorney Jonathan Orent appointed to lead Atrium C-QUR hernia mesh MDL

Motley Rice medical attorney Jonathan Orent has been appointed by Judge Landya B. McCafferty of the United States District Court of New Hampshire as lead counsel and a member of the Plaintiffs Executive Committee for hernia mesh multidistrict litigation filed against medical device manufacturer Atrium Medical Corp.

The litigation, In re Atrium Medical Corp. C-QUR Mesh Products Liability Litigation, MDL #2753, was filed on behalf of plaintiffs alleging harm caused by the Atrium C-QUR™ hernia mesh device. Plaintiffs allege that the hernia mesh is defective because of its design, which includes non-absorbable polypropylene coated with Omega-3 fatty acids. Atrium C-QUR™ devices can cause complications, including hernia recurrence, adhesions, bacterial infections, mesh migrations and other effects requiring additional surgeries to repair, the FDA reports. Complications can be quite severe, and even life threatening.

In addition to his most recent appointment, Jonathan has represented thousands of women as co-liaison counsel in transvaginal mesh litigation. He is also reviewing alleged harms caused by other hernia products, including Johnson & Johnson’s Ethicon Physiomesh® Flexible Composite, Composix® Kugel® mesh patches (manufactured by C.R. Bard subsidiary Davol) and all hernia mesh manufactured by C.R. Bard made of Marlex polypropylene.

“I am honored to continue fighting for plaintiffs as a leader in Atrium C-QUR™ litigation,” Jonathan said. “It is our hope that through this litigation, the safety of hernia mesh patients, and the public in general, will be enhanced as we challenge medical device manufacturers to raise the bar when it comes to the efficacy of their products before they are placed on the market and implanted into patients. We look forward to our day in court.”   

If you or someone you love suffered complications after being implanted with a hernia mesh device, you may contact Jonathan Orent by email or call 1.800.768.4026.